Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression

INTRODUCTION: The co-regulatory molecule, HVEM, can stimulate or inhibit immune function, but when co-expressed with BTLA, forms an inert complex preventing signaling. Altered HVEM or BTLA expression, separately have been associated with increased nosocomial infections in critical illness. Given tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakeley, Michelle E., Armstead, Brandon E., Gray, Chyna C., Tindal, Elizabeth W., Heffernan, Daithi S., Chung, Chun-Shiang, Ayala, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248445/
https://www.ncbi.nlm.nih.gov/pubmed/37305124
http://dx.doi.org/10.3389/fmed.2023.1176602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248445/
https://www.ncbi.nlm.nih.gov/pubmed/37305124
http://dx.doi.org/10.3389/fmed.2023.1176602

Ejemplares similares